Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global assisted reproductive technology market demand is slated to increase by 1.4x over the forecast period.
In-Vitro Fertilization (IVF) to Remain a Standard Assisted Reproductive Technology Procedure
The latest research report by Fact.MR on assisted reproductive technology market is intended to offer reliable data on various key factors shaping the growth curve and outlook of the market. It uncovers various trends and opportunities affecting the demand across leading segments including procedure, technology, end user, and region.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global assisted reproductive technology (ART) market demand is slated to increase by 1.4x over the forecast period. With rising infertility cases across the globe, sales of assisted reproductive technology are expected to surge at 6.3% CAGR through 2021 & beyond.
Robust expansion of assisted reproductive technology is also driven by rising prevalence of polycystic ovarian syndrome (PCOS), growing health awareness among people, and advancement in reproductive technology.
Assisted reproductive technology is a technology used to treat infertility by means of procedures such as in-vitro fertilization, artificial insemination, and surrogacy. Additionally, as per World Health Organization (WHO) statistics, around 48 million couples and 186 million individuals live with infertility across the globe. To reduce this global burden, people are opting for assisted reproductive technology procedures.
Consecutively, rising number of fertility clinics and increasing government initiatives to spread awareness is expected to significantly expand the ART market during the forecast period.
In terms of technology, in-vitro fertilization is expected to be the most preferred procedure for infertility on account of its higher success rate. In recent years, modified versions of IVF such as gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) have gained immense popularity among patients.
Sample Copy With Impact Analysis Of COVID-19 Of Market Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=4393
As per Fact.MR, fresh non-donor fertility procedure segment is expected to dominate the ART market owing to the high success rate of procedures using fresh embryos/eggs and natural desire for producing a child using one’s own sex gamete.
For instance, statistics of Centers for Disease Control and Prevention (CDC) opines, nearly 82% of pregnancies resulting from ART cycles use fresh non-donor eggs.
“With growing infertility cases across India, China, and Japan, need for fertility clinics has burgeoned across South and East Asia. Against this backdrop, ART market players are eyeing the South Asia and East Asia market to increase their revenues and expand customer base through strategic collaborations” says a Fact.MR analyst
Key Takeaways from Assisted Reproductive Technology Market Survey
- Europe is expected to dominate the assisted reproductive technology market on account of increasing infertility rate and surging demand for ART treatment across the U.K.
- With high acceptance of ART, the U.S. is estimated to be the most lucrative market for assisted reproductive technology
- China and India are poised to exhibit strong growth due to rising awareness among people, favorable government support, and increasing penetration of fertility clinics.
- Based on end user, fertility clinics segment is projected to contribute more than US$ 16.8 Bn in 2021.
Key Drivers
- Growing awareness among people coupled with increasing government initiatives to tackle infertility burden is favoring the growth of ART market.
- Higher success rate of ART procedures is expected to create conducive environment for the growth in the market.
- Technological advancements and product launches in reproductive technology will continue to support the growth in the market.
- Increasing number of fertility clinics along with establishment of sperm banks across developing regions is creating lucrative growth avenues within ART market.
Key Restraints
- High cost associated with assisted reproductive technology is restraining the growth of the market.
To gain in-depth insights on Assisted Reproductive Technology Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4393
Competitive Landscape
Leading players operating in the assisted reproductive technology market are focusing on expanding their global footprint. They have adopted various growth strategies such as mergers, partnerships, advanced product launches & approvals and acquisitions to dominate the market.
- In November 2021, CooperSurgical, Inc. signed a definitive purchase agreement to acquire Generate Life Science, a privately held, leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage, for around US$ 1.6 Bn. The acquisition will enhance CooperSurgical’s offering in both fertility solution and labor & delivery.
- In July 2018, Merck, a leading science and technology company, launched QBOX IVF and the new Geri Assess 2.0, in its continued drive to serve the needs of its customers and to become the preferred treatment partner for all IVF stakeholders and assisted reproductive treatment clinics.
- In July 2021, Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software and services to the assisted reproductive technologies (ART) research, and cell biology markets, completed the acquisition of IVFTECH ApS and its affiliated reseller arm, K4 Technology ApS.
- In July Vitrolife AB completed the acquisition of Igenomix S.L. the acquisition will help the company to expand its portfolio and provide its customers better service.
Some of the prominent players operating in the assisted reproductive technology market profiled by Fact.MR are:
- Merck KGaA
- Esco Micro Pte. Ltd.
- CooperSurgical, Inc.
- Planer PLC
- Vitrolife AB
- Laboratoire CCD
- Hamilton Thorne, Inc.
- Irvine Scientific
- Nikon Corporation
- Nidacon International AB
More Insights on the Global Assisted Reproductive Technology Sales Outlook
Fact.MR provides an unbiased analysis of assisted reproductive technology market, presenting historical demand data (2014-2019) and forecast statistics for the period from 2020-2025. The study divulges compelling insights on the global demand for assisted reproductive technology with a detailed segmentation on the basis of:
Procedure
- Frozen Donor
- Frozen Non-donor
- Fresh Donor
- Fresh Non-donor
- Embryo Banking
Technology
- In-vitro Fertilization
Intra-cytoplasmic Sperm Injection (ICSI)
Preimplantation Genetic Diagnosis (PGD)
- Surrogacy
- Artificial Insemination
Intrauterine Insemination (IUI)
Intracervical Insemination (ICI)
Others
- Others
End User
- Fertility Clinics
- Hospital
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Questions Covered in the Assisted Reproductive Technology Market Outlook Report
- The report offers insight into assisted reproductive technology demand outlook for 2020-2025
- The market study also highlights projected sales growth for assisted reproductive technology market between 2020 and 2025
- Assisted reproductive technology market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Assisted reproductive technology market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Cryopreservation & Fertilization Media Market Insights - Manufacturers in this industry are producing an improved version of cryopreservation and fertilization media with a shelf life ranging from 6 months to a year. Because IVF clinics, hospitals, and academic research centers are the primary end-users of cryopreservation and fertilization media, the availability of such advanced products will fuel demand. The demand for assisted reproductive technology (ART) therapies has increased dramatically as a result of the large number of infertility patients. This trend is expected to propel the market forward.
Computer-Assisted Orthopedic Surgery Market Forecast - Due to technology advancements in the healthcare system, computer-assisted orthopedic surgery will see rapid expansion. As a result, demand for computer-assisted orthopedic surgery is predicted to rise dramatically over the projection period. In the medical field, computer-assisted orthopedic surgery is gaining prominence. This need is mostly driven by the growing number of patients with skeletal and related illnesses. During the projected period, this is the key driver driving demand for computer-assisted orthopedic surgery, together with the growing older adult population.
Assistive Technologies Demand for Visually Impaired Market Scope - Assistive technologies have advanced significantly as a result of technological developments combined with proper research and development. Electronic mobility aids such as Ray and UltraCane have ushered in amazing advancements in the market for assistive technologies for the visually impaired. As a result of these technical breakthroughs, the need for assistive technologies for visually impaired people is expected to skyrocket. Other factors, such as an ageing population, an increase in incidences of visual impairment, and an increase in healthcare spending, will all contribute to an increase in demand for assistive technologies for the visually impaired.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR